This inventor holds 1 USPTO granted patent. Top assignee: Bay Development Corporation Sa. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovations of John-Erik Stig Hansen
Introduction
John-Erik Stig Hansen is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of medical research, particularly in the fight against HIV. His innovative approach has led to the development of a unique method that utilizes antibodies to combat the progression of AIDS.
Latest Patents
Hansen holds a patent for a method of using an antibody to the TN antigen for the inhibition of HIV. This patent describes how a monoclonal or other antibody to the carbohydrate antigen Tn can be employed to inhibit or slow the progression of AIDS or AIDS-related complex (ARC). The antigen can also be utilized in a vaccine for immunization purposes. This groundbreaking work highlights Hansen's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Hansen is associated with Bay Development Corporation SA, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in his organization. His work not only reflects his expertise but also his passion for making a difference in healthcare.
Collaborations
Hansen collaborates with Henrik Clausen, who is also involved in the research and development efforts at Bay Development Corporation SA. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant breakthroughs in medical research.
Conclusion
John-Erik Stig Hansen's contributions to the field of medical research, particularly through his patent on the inhibition of HIV, demonstrate his innovative spirit and commitment to improving health outcomes. His work continues to inspire future advancements in the fight against AIDS.